Why the study?
Does ivabradine reduce heart rate and improve symptoms in a patient with cardiomyopathy induced by inappropriate sinus tachycardia?
Does ivabradine reduce heart rate and improve symptoms in a patient with cardiomyopathy induced by inappropriate sinus tachycardia?
Ivabradine may be an effective second-line treatment for patients with very symptomatic and refractory inappropriate sinus tachycardia.
No takes yet. Share an insight, caveat, or question.
Ivabradine may aid recovery in IST cardiomyopathy; single case leaves open need for prospective trials.
Winum et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: